Dextromethorphan is principally a sigma receptor agonist and an SNRI, and dextromethorphan's outcomes being a dissociative hallucinogen can be attributed partially to dextrorphan (DXO), a metabolite produced when dextromethorphan is metabolized by the body. Both of those dextrorphan and dextromethorphan are NMDA receptor antagonists,[32] alike othe

Article Under Review